reports
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising ...
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts SCOTTSDALE, Ariz., May 13, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, signed an agreement engaging Capstone Partners, a full-service middle market investment bank with specialization in refranchising. President and Chief Executive Officer Peter D. Holt said, “As we continue our strategy to refranchise the vast majority of our corporate clinic portfolio, it is imperative we select the most effective franchis...
- Franc Gregori
- Lala Gregorek
- Philippa Gardner
Trinity Delta Lighthouse: HUTCHMED
Trinity Delta view: Partner Takeda has executed an impressive initial launch of Fruzaqla in the US, which provides confidence in future successful launches in Europe and Japan (once regulatory approvals are secured), and for Fruzaqla’s longer-term growth prospects with expansion to additional indications. Fruzaqla’s commercial prospects are a key contributor to HUTCHMED’s path to profitability, which is supported by the growing traction and market share capture of its China oncology products, pl...
Incar Financial Service Co Ltd: 1 director
A director at Incar Financial Service Co Ltd sold 10,500 shares at 5,604.609KRW and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Newron Reports Compelling Additional Data Documenting the Efficacy of ...
MILAN--(BUSINESS WIRE)-- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), presents additional results from the international, randomized, double-blind, placebo-controlled study 008A that evaluated the efficacy and safety of evenamide (30 mg bid) as add-on treatment in 291 patients not benefitting from their second-generation antipsychotic medication, including clozapine. Initial top line data announced on 30th April 2024 demon...
Iterum Therapeutics Reports First Quarter 2024 Financial Results
Iterum Therapeutics Reports First Quarter 2024 Financial Results --NDA Resubmitted; FDA Action Expected in Early Q4 24-- --Cash Runway into 2025, including through Potential FDA Approval-- --Company to Host Conference Call Today at 8:30 a.m. EDT-- DUBLIN, Ireland and CHICAGO, May 13, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (Iterum) a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported fi...
CECO Environmental Announces Upcoming Investor Conferences
CECO Environmental Announces Upcoming Investor Conferences DALLAS, May 13, 2024 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that Todd Gleason, Chief Executive Officer, and Peter Johansson, Chief Financial and Strategy Officer, will present at the following investor conferences: May 23, 2024 – TD Cowen 2nd Annual Sustainability Week.May 29, 2024 – The 21st Annual Craig-Hallum Institutional Investor Conference in Minne...
Praxis Precision Medicines Provides Corporate Update and Reports First...
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results Plans to initiate two efficacy studies investigating PRAX-628 in focal onset seizures in the second half of 2024 and first half of 2025, respectively Continued strong recruitment for the pivotal Essential3 trials in Essential Tremor (ET), with over 50,000 pre-screening forms and over 7,000 referrals received to date that meet pre-qualifying eligibility criteria; topline results expected in the second half of 2024 Randomization in PRAX-562 Phase 2 EMBOLD study completed in pediatric pati...
Village Farms International Appoints Finance and Operations Veteran Ca...
Village Farms International Appoints Finance and Operations Veteran Carolyn Hauger to Board VANCOUVER, British Columbia and ORLANDO, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF) is delighted to announce that Carolyn Hauger has been appointed to its Board of Directors, effective immediately, and will stand for election at the Company’s annual shareholders meeting in June 2024. Ms. Hauger has extensive finance, operations and public company director experience having served as CFO for a variety of companies, where ...
Fulcrum Therapeutics Announces Recent Business Highlights and Financia...
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 ― Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ― ― On track to report topline data for Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in the fourth quarter of 2024 ― ― Industry veteran, Patrick Horn M.D., Ph.D., appointed as chief medical officer ― ― Conference call and webcast scheduled for 8:00 a.m. ET today ― CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Fulcr...
Aya Gold & Silver Extends Main Zone to 5km and Adds 7 New Permits at B...
Aya Gold & Silver Extends Main Zone to 5km and Adds 7 New Permits at Boumadine MONTREAL, May 13, 2024 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2024 program of 120,000 meters (“m”) at Boumadine in the Kingdom of Morocco. Today’s results extend the main mineralized trend by 800m and continues to demonstrate continuity of the Boumadine Main Zone, which remains open in all directions. The Corporation also reports it has secured the right to 7 additional exploration ...
Mirasol Identifies New Porphyry Targets at the El Potro Prospect and a...
Mirasol Identifies New Porphyry Targets at the El Potro Prospect and also Extends the VN-Zone by more than 3 km at the Sobek Copper-Gold Project in Vicuña District, Chile Two new porphyry target areas, have been defined and supported by coincident alteration, geophysics and geochemistry The size of the alteration and mineralization footprint suggests that the VN-Zone may represent a much larger porphyry system which extends for at least another 3km to the southA new copper porphyry target at El Potro prospect quickly advancing to drill ready stageThe VN-Zone is located 7 km directly west of...
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced . (OTCQX: BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, has qualified to trade on the OTCQX® Best Market. BioLargo, Inc. upgraded to OTCQX from the OTCQB® Venture Market. BioLargo, Inc. begins trading today on OTCQX under the symbol “BLGO.” U.S. investors can find current financial disclosure and Rea...
Cibus to Participate in the BMO Global Farm to Market Conference
Cibus to Participate in the BMO Global Farm to Market Conference SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the BMO Global Farm to Market Conference taking place May 15-16, 2024. Presentation detailsDate: Thur...
Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Dr...
Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Drive Strategic Growth and Build Market Leadership IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced the appointment of Mathi Gurusamy as its chief strategy officer (CSO), effective May 13, 2024. In his new role, Gurusamy will spearhead the company’s strategic planning and execution of growth opportunities, manage merger and acquisition activities, and drive go-to-market strategies that address key IoT technology trends to bolster...
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConn...
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference on Monday, May 20, 2024, at 3:00 p.m. ET. A live webcast of the fireside chat can be accessed through the Even...
Abacus Life Reports First Quarter 2024 Results
Abacus Life Reports First Quarter 2024 Results - First Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $21.5 Million - - Driven by 59% Year-over-Year Growth in Direct-to-Consumer Division - ORLANDO, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the first quarter ended March 31, 2024. “We are pleased with our continued momentum, delivering yet another strong quarterly performance due to our relentless e...
Bitfarms Announces Acceleration of Previously Announced Termination of...
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on New CEO Appointment - Geoffrey Morphy terminated as CEO and Nicolas Bonta appointed on interim basis -- CEO Executive search nearing completion - This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, May 13, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integr...
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual...
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting ASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of the abstract presented at AACR 2024. Medicenna disagrees with ASCO’s decision as the AACR 2024 abstract was limited to on-going interim results whereas the ASCO 2024 abstract specified data from a completed phase 1 study that were not presented at AACR 2024. No other matters were raised by ASCO regarding any data included i...
Talisker Signs Ore Hauling Agreement for Bralorne Gold Project
Talisker Signs Ore Hauling Agreement for Bralorne Gold Project TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce that the Company, through its 100% owned subsidiary Bralorne Gold Mines Ltd. (“Bralorne”), has signed an Ore Hauling Agreement (the “Ore Hauling Agreement”) with Stromsten Enterprises in partnership with Bridge River Management Corporation to transport material from its 100% owned Mustang Mine at the Bralorne Gold Project located in British Columbia. Under the Ore Hauling Agreement, go...
Bitfarms Reschedules First Quarter Conference Call to May 15th at 8:00...
Bitfarms Reschedules First Quarter Conference Call to May 15th at 8:00am ET TORONTO and BROSSARD, Québec, May 13, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin mining company, announces that it will report first quarter results on Wednesday, May 15, 2024, before the market opens. As a result, the conference call has been rescheduled for the same day at 8:00 am ET. A presentation of the Q1 2024 results will be accessible before the call on the Investor website and can be accessed . Participants may join by calling 877-545-0523 (domestic)...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.